Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Succinate dehydrogenase complex—also known as electron transport chain Complex II—is a multi-subunit enzyme embedded within the inner mitochondrial membrane. It uniquely participates both as an enzyme catalyzing oxidation of succinate to fumarate within the citric acid cycle and as an integral component transferring electrons from FADH₂ produced by this reaction directly into the electron transport chain via reduction of ubiquinone. The human enzyme consists of four subunits (SDHA, SDHB, SDHC, SDHD), with two hydrophilic catalytic subunits facing the matrix and two hydrophobic membrane anchor subunits. Unlike other complexes I/III/IV that pump protons across the membrane contributing directly to proton gradient formation for ATP synthesis, Complex II does not translocate protons but still contributes indirectly by feeding electrons into downstream complexes that do pump protons. Mutations affecting any subunit can result in inherited cancer predisposition syndromes or severe neurometabolic disease due to impaired oxidative phosphorylation capacity.
For inhibitors: - Competitive inhibition at the succinate binding site or quinone binding site blocks electron transfer from succinate to ubiquinone. For potential therapeutics: - Modulation may alter mitochondrial respiration, ATP production, or reactive oxygen species generation.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Succinate dehydrogenase complex (SDH or Complex II).